Dapagliflozin Pharmacokinetics Is Similar in Adults with Type 1 and Type 2 Diabetes Mellitus.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of clinical pharmacology"
DOI: 10.1002/jcph.2062
Abstract: Dapagliflozin improves glycemic control in patients with type 2 diabetes mellitus (T2DM) and is approved in Japanese patients with type 1 diabetes mellitus (T1DM) with inadequate glycemic control. The objectives of this work were to… read more here.
Keywords: patients t1dm; dapagliflozin systemic; dapagliflozin pharmacokinetics; type diabetes ... See more keywords